Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basal Bolus Insulin Analogs vs Human Insulin in T2D Inpatients
NCT02278913Phase 4Completed
- Sponsor
- Universidad Nacional de Asunción
- Start
- Apr 2009
- Primary completion
- Apr 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine and insulin glulisine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Universidad Nacional de Asunción. Primary endpoint: Mean Daily Blood Glucose Concentration. Started Apr 2009; status: completed.
02
Drugs
insulin glargineinsulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02278913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02278913.